Abstract
A 52-year-old woman complaining of breast tumor was diagnosed as having advanced breast cancer (T4bN1M1-Stage IV), with metastasis of multiple organs (lung, liver, mediastinal and unilateral axillary lymph nodes) after which she underwent tumorectomy. Postoperative adjuvant therapy was performed using combined chemoendocrine therapy (CAF + 5'-DFUR + MPA). Following the endocrine therapy, the metastatic lesions of the liver and lung had disappeared. The adverse effects were not remarkable. Complete remission was continued for 2 years and 3 months, and the patient enjoyed a favorable quality of life.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / pathology
-
Breast Neoplasms / surgery
-
Chemotherapy, Adjuvant
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Doxorubicin / administration & dosage
-
Drug Administration Schedule
-
Female
-
Floxuridine / administration & dosage
-
Fluorouracil / administration & dosage
-
Humans
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / secondary*
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / secondary*
-
Lymphatic Metastasis
-
Mastectomy
-
Medroxyprogesterone Acetate / administration & dosage
-
Middle Aged
-
Remission Induction
Substances
-
Floxuridine
-
Doxorubicin
-
Cyclophosphamide
-
Medroxyprogesterone Acetate
-
Fluorouracil
-
doxifluridine